Minimally Invasive Diagnosis of Acquired Immunodeficiency Syndrome-Related Primary Central Nervous System Lymphoma
Open Access
- 4 March 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 90 (5) , 364-369
- https://doi.org/10.1093/jnci/90.5.364
Abstract
Background: The detection of Epstein-Barr virus (EBV)-DNA in cerebrospinal fluid (CSF) by means of the polymerase chain reaction (PCR) has been revealed, in retrospective studies, to be a good marker of primary central nervous system lymphoma (PCNSL) related to acquired immunodeficiency syndrome (AIDS); however, the technique's usefulness in the management of AIDS patients with focal brain lesions is still unknown. We studied the clinical usefulness of testing CSF obtained by lumbar puncture for the presence of EBV-DNA as a minimally invasive approach to the diagnosis of AIDS-PCNSL in patients with focal brain lesions. Methods: Human immunodeficiency virus (HIV)-infected patients with focal brain lesions, observed prospectively during a 30-month period, underwent lumbar puncture if not contraindicated; otherwise, ventricular CSF was obtained at brain biopsy. The presence of EBV-DNA was determined by means of PCR. Results: We evaluated 122 patients: 42 diagnosed with brain lymphoma and the remaining 80 diagnosed with other brain disorders. Cerebrospinal fluid was collected from 101 patients—by lumbar puncture in 95, including 40 patients with AIDS-PCNSL. The sensitivity and specificity of PCR for EBV-DNA detection in lumbar CSF were 80% (95% confidence interval [CI] = 60.9%–91.6%) and 100% (95% CI = 92.6%–100%), respectively. Lumbar puncture and subsequent assessment of EBV-DNA would have allowed a correct diagnosis in 63.2% (95% CI = 46.0%– 77.7%) of patients with AIDS-PCNSL and excluded this diagnosis in 76.3% (95% CI = 65.2%–84.8%) of patients without lymphoma (because EBV-DNA was not detected). Conclusions: The presence of EBV-DNA in lumbar CSF is a sensitive and highly specific diagnostic marker of AIDS-PCNSL, and EBV-DNA detection in this fluid may allow a minimally invasive diagnosis in a large percentage of patients with brain lymphomas.Keywords
This publication has 27 references indexed in Scilit:
- The Impact of Primary Central Nervous System Lymphoma in AIDS PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Toxoplasmic encephalitis in HIV-infected persons: risk factors and trendsAIDS, 1996
- Epidemiology of Brain Lymphoma Among People With or Without Acquired Immunodeficiency SyndromeJNCI Journal of the National Cancer Institute, 1996
- Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitisAIDS, 1995
- Management of primary central nervous system lymphoma for the patient with acquired immunodeficiency syndrome. Confronting a clinical catch-22Cancer, 1995
- Temporal trends in the incidence of HTV‐1‐related neurologic diseasesNeurology, 1994
- Dapsone-Pyrimethamine Compared with Aerosolized Pentamidine as Primary Prophylaxis against Pneumocystis carinii Pneumonia and Toxoplasmosis in HIV InfectionNew England Journal of Medicine, 1993
- The Efficacy of Image-Guided Stereotactic Brain Biopsy in Neurologically Symptomatic Acquired Immunodeficiency Syndrome PatientsNeurosurgery, 1992
- Primary central nervous system lymphoma in acquired immune deficiency syndrome. A clinical and pathologic study with results of treatment with radiationCancer, 1991
- Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndromeJournal of Neurosurgery, 1990